<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="correction"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Crit Care</journal-id><journal-title>Critical Care</journal-title><issn pub-type="ppub">1364-8535</issn><issn pub-type="epub">1466-609X</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">2646344</article-id><article-id pub-id-type="publisher-id">cc7107</article-id><article-id pub-id-type="doi">10.1186/cc7107</article-id><article-categories><subj-group subj-group-type="heading"><subject>Correction</subject></subj-group></article-categories><title-group><article-title>The role of corticosteroids in severe community-acquired pneumonia: a systematic review</article-title></title-group><contrib-group><contrib id="A1" corresp="yes" contrib-type="author"><name><surname>Salluh</surname><given-names>Jorge IF</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><email>jorgesalluh@yahoo.com.br</email></contrib><contrib id="A2" contrib-type="author"><name><surname>P&#x000f3;voa</surname><given-names>Pedro</given-names></name><xref ref-type="aff" rid="I3">3</xref></contrib><contrib id="A3" contrib-type="author"><name><surname>Soares</surname><given-names>M&#x000e1;rcio</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib id="A4" contrib-type="author"><name><surname>Castro-Faria-Neto</surname><given-names>Hugo C</given-names></name><xref ref-type="aff" rid="I2">2</xref></contrib><contrib id="A5" contrib-type="author"><name><surname>Bozza</surname><given-names>Fernando A</given-names></name><xref ref-type="aff" rid="I4">4</xref></contrib><contrib id="A6" contrib-type="author"><name><surname>Bozza</surname><given-names>Patr&#x000ed;cia T</given-names></name><xref ref-type="aff" rid="I2">2</xref></contrib></contrib-group><aff id="I1"><label>1</label>Intensive Care Unit, Instituto Nacional de C&#x000e2;ncer, Pra&#x000e7;a Cruz Vermelha, 23, 10 andar &#x02013; Centro, Rio de Janeiro-RJ, Brazil 20230-130</aff><aff id="I2"><label>2</label>Immunopharmacology Laboratory, Instituto Oswaldo Cruz, FIOCRUZ, Av. Brasil, 4365, Rio de Janeiro-RJ, Brazil 21045-900</aff><aff id="I3"><label>3</label>Medical Intensive Care Unit, Hospital de S&#x000e3;o Francisco Xavier. Centro Hospitalar de Lisboa Ocidental, Estrada do Forte do Alto do Duque, CEP 1449-005 Lisboa, Portugal</aff><aff id="I4"><label>4</label>Instituto de Pesquisa Cl&#x000ed;nica Evandro Chagas, Funda&#x000e7;&#x000e3;o Oswaldo Cruz, Av. Brasil, 4365, Rio de Janeiro-RJ, Brazil 21045-900</aff><pub-date pub-type="ppub"><year>2008</year></pub-date><pub-date pub-type="epub"><day>7</day><month>11</month><year>2008</year></pub-date><volume>12</volume><issue>6</issue><fpage>434</fpage><lpage>434</lpage><ext-link ext-link-type="uri" xlink:href="http://ccforum.com/content/12/6/434"/><permissions><copyright-statement>Copyright &#x000a9; 2008 BioMed Central Ltd</copyright-statement><copyright-year>2008</copyright-year><copyright-holder>BioMed Central Ltd</copyright-holder></permissions><related-article related-article-type="corrected-article" vol="12" page="R76" id="N0x1e42fd0N0x33a90f0" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="18547407" ext-link-type="pubmed"/></article-meta></front><body><sec><title/><p>Following the publication of the above article [<xref ref-type="bibr" rid="B1">1</xref>], we noticed that in Table <xref ref-type="table" rid="T1">1</xref>, concerning the data of the study from Garcia-Vidal the dose of methylprednisolone is not 14.5 mg/day but 45 mg/day.</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Recent literature on the role of corticosteroids in severe community-acquired pneumonia</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left">Reference</td><td align="left">Study design</td><td align="center">Sample size, number</td><td align="left">Patient selection</td><td align="left">Corticosteroids (drug/regimen)</td><td align="left">Primary endpoints</td><td align="left">Level of evidence and recommendation</td></tr></thead><tbody><tr><td align="left">Marik, <italic>et al</italic>. [21]</td><td align="left">Single-center RCT</td><td align="center">30</td><td align="left">Severe CAP</td><td align="left">Hydrocortisone 10 mg/kg versus placebo 30 minutes before antibiotics</td><td align="left">Mortality, clinical course, and serum TNF-&#x003b1; levels</td><td align="left">Weak recommendation, moderate-quality evidence</td></tr><tr><td align="left">Confalonieri, <italic>et al</italic>. [6]</td><td align="left">Multicenter RCT</td><td align="center">46</td><td align="left">Severe CAP</td><td align="left">Hydrocortisone 200 mg + hydrocortisone 10 mg/hour, for 7 days versus placebo</td><td align="left">Mortality, clinical course, and Systemic inflammation</td><td align="left">Strong recommendation, moderate-quality evidence</td></tr><tr><td align="left">Mikami, <italic>et al</italic>. [20]</td><td align="left">Open label RCT</td><td align="center">31</td><td align="left">Moderate and severe CAP</td><td align="left">Prednisolone 40 mg qd, for 3 days versus placebo</td><td align="left">Mortality and clinical course</td><td align="left">Weak recommendation, low-quality evidence</td></tr><tr><td align="left">Garcia-Vidal, <italic>et al</italic>. [19]</td><td align="left">Retrospective cohort study</td><td align="center">308</td><td align="left">Severe CAP</td><td align="left">Methylprednisolone 45 mg (or equivalent) qd for 11.4 days</td><td align="left">Mortality</td><td align="left">Strong recommendation, low-quality evidence</td></tr></tbody></table><table-wrap-foot><p>CAP, community-acquired pneumonia; qd, <italic>quaque die </italic>(every day); RCT, randomized controlled trial; TNF-&#x003b1;, tumor necrosis factor-alpha.</p></table-wrap-foot></table-wrap></sec><sec><title>Competing interests</title><p>The authors declare that they have no competing interests.</p></sec></body><back><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Salluh</surname><given-names>JI</given-names></name><name><surname>Povoa</surname><given-names>P</given-names></name><name><surname>Soares</surname><given-names>M</given-names></name><name><surname>Castro-Faria-Neto</surname><given-names>HC</given-names></name><name><surname>Bozza</surname><given-names>FA</given-names></name><name><surname>Bozza</surname><given-names>PT</given-names></name></person-group><article-title>The role of corticosteroids in severe community-acquired pneumonia: a systematic review</article-title><source>Crit Care</source><year>2008</year><volume>12</volume><fpage>R76</fpage><pub-id pub-id-type="pmid">18547407</pub-id><pub-id pub-id-type="doi">10.1186/cc6922</pub-id></citation></ref></ref-list></back></article>